Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Independent Naturopathic Clinic Receives Groundbreaking Research Grant: Partners with Global Pharmaceutical Company to Study Relief of Cancer Drug Side Effects
  • USA - English


News provided by

Five Spot Health Communications

Nov 05, 2013, 06:00 ET

Share this article

Share toX

Share this article

Share toX


Seattle, WA (PRWEB) November 05, 2013 -- Northwest Natural Health Specialty Care Clinic (NNH) announced today it has been awarded a $560,000 research grant by Millennium: The Takeda Oncology Company to conduct a multiple clinical site investigation into the use of natural medicine to mitigate a side effect of bortezomib (Velcade®), an FDA approved, new generation targeted chemotherapy approved for the treatment of multiple myeloma and other cancers.

By investing in this unique partnership with Northwest Natural Health, we will advance our ability to provide cancer patients with the very best care that science can provide.

Post this

NNH created the research protocol for this FDA approved, double blinded, placebo-controlled trial and will direct its implementation at 5 clinical research institutions: Swedish Cancer Institute (part of Swedish Medical Center) in Seattle WA, Island Hospital in Anacortes WA, Yakima Valley Memorial Hospital (Northstar Lodge) in Yakima WA, Cancer Care Northwest in Spokane WA, and Northwest Medical Specialties in Puyallup WA.

The trial will run for 2 years and focus on mitigating a potential side effect of Velcade®, peripheral neuropathy, a numbness of the fingers and toes. This clinical investigation utilizes a combination of a natural amino acid (amino acids are the building blocks of dietary protein) and a special form of a B vitamin to limit Velcade® induced neuropathy.

“This clinical trial is consistent with Millennium: The Takeda Oncology Company’s commitment to continually improve cancer care,” said Randy Everett, Scientific Alliances & Research, Global Medical Affairs at Millennium. “By investing in this unique partnership with Northwest Natural Health Specialty Care Clinic, we will advance our ability to provide cancer patients with the very best care that science can provide.”

The principal investigators for this trial are Dan Labriola ND, director of NNH and Hakan Kaya MD, medical oncologist, hematologist and researcher at Cancer Care Northwest.

“Natural medicines have been used successfully throughout history to treat and prevent disease, relieve suffering and improve quality of life. This clinical trial will provide hard scientific data for one of the many opportunities to combine the best of both worlds, naturopathic care and conventional medicine,” said Labriola.

“Swedish Medical Center is best known for quality patient care but also conducts clinical research in many specialties,” said Marcel Loh, Interim Chief Executive Officer, Swedish Medical Center. “There are currently more than 600 clinical trials in progress at Swedish. This clinical trial partnership with Northwest Natural Health Clinic is one more example of how we strive to make healthcare as effective and efficient as possible.”

About Northwest Natural Health Clinic

Northwest Natural Health Clinic (NNH) and its founder, Dr. Labriola, have provided coordinated integrative care in outpatient and in-hospital settings for more than 28 years. The clinic is an internationally recognized expert in the safe and effective incorporation of the benefits of naturopathic care to improve treatment outcomes and patient quality of life. Their groundbreaking naturopathic approach especially benefits patients receiving specialty medical care for cancer, heart disease, neurologic, women's health, gastrointestinal, immune system, elder care issues and more. NNH naturopathic physicians are specially trained, accredited and published in major scientific journals.

About Millennium: The Takeda Oncology Company

Millennium, the oncology arm of Takeda Pharmaceutical Company Limited, located in Cambridge Massachusetts, combines the innovative science of a leading American biopharmaceutical company with the global assets – both intellectual and fiscal – of Japan's largest pharmaceutical company. Millennium’s mission is to deliver extraordinary medicines like Velcade® for the treatment of multiple myeloma to patients throughout the world. Millennium is passionately committed to science, innovation and patient health.

Patient Safety Information

Vitamins, minerals, amino acids, herbs and other supplements can, in certain circumstances, interfere with treatments for cancer and other diseases. Patients should not self-treat with supplements outside of the controlled environment of this clinical trial without first discussing this with their physician.

For media inquiries, contact:
Laura E. Peterson
Five Spot Health Communications
For: Northwest Natural Health Clinic
6135 Seaview Avenue Northwest #300 Seattle, WA 98107
Seattle, WA 98107
Phone: 425.890.0095

Laura Peterson, Five Spot Health Communications, http://fivespotcommunications.com/, +1 425.890.0095, [email protected]

Modal title

What's Being Said About this Clinical Trial - Millennium and Northwest Natural Health
View PDF
What's Being Said About this Clinical Trial - Millennium and Northwest Natural Health
What's Being Said About this Clinical Trial - Millennium and Northwest Natural Health

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.